Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels
Authors:
- G. GilbertGGG. Gilbert
- P. LoryPLP. Lory
- R. MarthanRMR. Marthan
- J.F. QuignardJQJ.F. Quignard
- J.P. SavineauJSJ.P. Savineau
- 1 June 2012
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 83 (11) , 1530-1539
Abstract
No abstract availableKeywords
Funding Information
- Université Bordeaux Segalen
This publication has 43 references indexed in Scilit:
- Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertensionPharmacology & Therapeutics, 2010
- Dehydroepiandrosterone Reverses Systemic Vascular Remodeling Through the Inhibition of the Akt/GSK3-β/NFAT AxisCirculation, 2009
- Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: Mechanism of action and relevance to psychiatric disordersProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Dehydroepiandrosterone Stimulates Endothelial Proliferation and Angiogenesis through Extracellular Signal-Regulated Kinase 1/2-Mediated MechanismsEndocrinology, 2007
- Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptorSteroids, 2004
- Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertensionProceedings of the National Academy of Sciences, 2003
- Androgen biosynthesis from cholesterol to DHEAMolecular and Cellular Endocrinology, 2002
- Androgens and aging menMolecular and Cellular Endocrinology, 2002
- Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal womenEuropean Journal of Endocrinology, 2001
- Effects of Dehydroepiandrosterone Sulfate on Cellular Calcium Responsiveness and Vascular ContractilityHypertension, 1995